{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:58:00Z","timestamp":1764251880276},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00059-024-05246-1","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T14:01:43Z","timestamp":1715004103000},"page":"233-246","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapie mit kardialen elektronischen implantierbaren Devices","Treatment with cardiac electronic implantable devices"],"prefix":"10.1007","volume":"49","author":[{"given":"J\u00fcrgen","family":"Kuschyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Sattler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Fastenrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Rudic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,6]]},"reference":[{"key":"5246_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.jchf.2023.07.002","volume":"11","author":"HM Salah","year":"2023","unstructured":"Salah\u00a0HM, Fudim\u00a0M, Burkhoff\u00a0D (2023) Device interventions for heart failure. JACC Heart Fail 11:1039\u20131054","journal-title":"JACC Heart Fail"},{"key":"5246_CR2","unstructured":"Mullens W, Dauw J, Gustafsson F et\u00a0al (2024) Integration of implantable device therapy in patients with heart failure. A\u00a0clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). Eur J Heart Fail"},{"key":"5246_CR3","doi-asserted-by":"crossref","unstructured":"Ellenbogen KA, Auricchio A, Burri H et\u00a0al (2023) The evolving state of cardiac resynchronization therapy and conduction system pacing: 25\u00a0years of research at EP Europace journal. Europace 25:","DOI":"10.1093\/europace\/euad168"},{"key":"5246_CR4","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","volume":"42","author":"M Glikson","year":"2021","unstructured":"Glikson\u00a0M, Nielsen\u00a0JC, Kronborg\u00a0MB et\u00a0al (2021) 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart\u00a0J 42:3427\u20133520","journal-title":"Eur Heart J"},{"key":"5246_CR5","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.jacc.2016.02.051","volume":"67","author":"AB Curtis","year":"2016","unstructured":"Curtis\u00a0AB, Worley\u00a0SJ, Chung\u00a0ES et\u00a0al (2016) Improvement in clinical outcomes with Biventricular versus right ventricular pacing: the BLOCK HF study. J\u00a0Am Coll Cardiol 67:2148\u20132157","journal-title":"J Am Coll Cardiol"},{"key":"5246_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/joa3.12872","volume":"39","author":"MK Chung","year":"2023","unstructured":"Chung\u00a0MK, Patton\u00a0KK, Lau\u00a0CP et\u00a0al (2023) 2023 HRS\/APHRS\/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. J\u00a0Arrhythm 39:681\u2013756","journal-title":"J Arrhythm"},{"key":"5246_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jacep.2016.02.007","volume":"2","author":"MP Turakhia","year":"2016","unstructured":"Turakhia\u00a0MP, Cao\u00a0M, Fischer\u00a0A et\u00a0al (2016) Reduced mortality associated with quadripolar compared to bipolar left ventricular leads in cardiac resynchronization therapy. JACC Clin Electrophysiol 2:426\u2013433","journal-title":"JACC Clin Electrophysiol"},{"key":"5246_CR8","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1093\/europace\/euaa411","volume":"23","author":"W Mullens","year":"2021","unstructured":"Mullens\u00a0W, Auricchio\u00a0A, Martens\u00a0P et\u00a0al (2021) Optimized implementation of cardiac resynchronization therapy: a\u00a0call for action for referral and optimization of care. Europace 23:1324\u20131342","journal-title":"Europace"},{"key":"5246_CR9","doi-asserted-by":"crossref","unstructured":"Leyva F, Zegard A, Patel P et\u00a0al (2023) Timing of cardiac resynchronization therapy implantation. Europace 25:","DOI":"10.1093\/europace\/euad059"},{"key":"5246_CR10","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/europace\/euad044","volume":"25","author":"H Burri","year":"2023","unstructured":"Burri\u00a0H, Jastrzebski\u00a0M, Cano\u00a0O et\u00a0al (2023) EHRA clinical consensus statement on conduction system pacing implantation: executive summary. Endorsed by the Asia-Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS) and Latin-American Heart Rhythm Society (LAHRS). Europace 25:1237\u20131248","journal-title":"Europace"},{"key":"5246_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jacep.2020.08.015","volume":"7","author":"P Vijayaraman","year":"2021","unstructured":"Vijayaraman\u00a0P, Ponnusamy\u00a0S, Cano\u00a0O et\u00a0al (2021) Left bundle branch area pacing for cardiac Resynchronization therapy: results from the international LBBAP collaborative study group. JACC Clin Electrophysiol 7:135\u2013147","journal-title":"JACC Clin Electrophysiol"},{"key":"5246_CR12","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.jacep.2023.04.015","volume":"9","author":"JC Diaz","year":"2023","unstructured":"Diaz\u00a0JC, Sauer\u00a0WH, Duque\u00a0M et\u00a0al (2023) Left bundle branch area pacing versus biventricular pacing as initial strategy for cardiac resynchronization. JACC Clin Electrophysiol 9:1568\u20131581","journal-title":"JACC Clin Electrophysiol"},{"key":"5246_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jacc.2023.05.006","volume":"82","author":"P Vijayaraman","year":"2023","unstructured":"Vijayaraman\u00a0P, Sharma\u00a0PS, Cano\u00a0O et\u00a0al (2023) Comparison of left bundle branch area pacing and biventricular pacing in candidates for resynchronization therapy. J\u00a0Am Coll Cardiol 82:228\u2013241","journal-title":"J Am Coll Cardiol"},{"key":"5246_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.hrthm.2023.09.021","volume":"21","author":"D Masarone","year":"2024","unstructured":"Masarone\u00a0D, Kittleson\u00a0MM, D\u2019onofrio\u00a0A et\u00a0al (2024) Basic science of cardiac contractility modulation therapy: molecular and electrophysiological mechanisms. Heart Rhythm 21:82\u201388","journal-title":"Heart Rhythm"},{"key":"5246_CR15","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","volume":"6","author":"WT Abraham","year":"2018","unstructured":"Abraham\u00a0WT, Kuck\u00a0KH, Goldsmith\u00a0RL et\u00a0al (2018) A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC Heart Fail 6:874\u2013883","journal-title":"JACC Heart Fail"},{"key":"5246_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/ejhf.2202","volume":"23","author":"J Kuschyk","year":"2021","unstructured":"Kuschyk\u00a0J, Falk\u00a0P, Demming\u00a0T et\u00a0al (2021) Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system. Eur J Heart Fail 23:1160\u20131169","journal-title":"Eur J Heart Fail"},{"key":"5246_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","volume":"3","author":"WT Abraham","year":"2015","unstructured":"Abraham\u00a0WT, Zile\u00a0MR, Weaver\u00a0FA et\u00a0al (2015) Baroreflex activation therapy for the treatment of heart failure with a\u00a0reduced ejection fraction. JACC Heart Fail 3:487\u2013496","journal-title":"JACC Heart Fail"},{"key":"5246_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ehf2.14136","volume":"10","author":"P Paolisso","year":"2023","unstructured":"Paolisso\u00a0P, Dagan\u00a0A, Gallinoro\u00a0E et\u00a0al (2023) Aortic thoracic neuromodulation in heart failure with preserved ejection fraction. ESC Heart Fail 10:699\u2013704","journal-title":"ESC Heart Fail"},{"key":"5246_CR19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jchf.2022.05.009","volume":"10","author":"M Fudim","year":"2022","unstructured":"Fudim\u00a0M, Zirakashvili\u00a0T, Shaburishvili\u00a0N et\u00a0al (2022) Transvenous right greater splanchnic nerve ablation in heart failure and preserved ejection fraction: first-in-human study. JACC Heart Fail 10:744\u2013752","journal-title":"JACC Heart Fail"},{"key":"5246_CR20","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K, Tfelt-Hansen\u00a0J, De Riva\u00a0M et\u00a0al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart\u00a0J 43:3997\u20134126","journal-title":"Eur Heart J"},{"key":"5246_CR21","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","volume":"375","author":"L Kober","year":"2016","unstructured":"Kober\u00a0L, Thune\u00a0JJ, Nielsen\u00a0JC et\u00a0al (2016) Defibrillator implantation in patients with nonischemic systolic heart failure. N\u00a0Engl J Med 375:1221\u20131230","journal-title":"N Engl J Med"},{"key":"5246_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.121.056072","volume":"145","author":"A Yafasova","year":"2022","unstructured":"Yafasova\u00a0A, Butt\u00a0JH, Elming\u00a0MB et\u00a0al (2022) Long-term follow-up of DANISH (the Danish study to assess the efficacy of ICDs in patients with nonischemic systolic heart failure on mortality). Circulation 145:427\u2013436","journal-title":"Circulation"},{"key":"5246_CR23","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA Mcdonagh","year":"2021","unstructured":"Mcdonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M et\u00a0al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart\u00a0J 42:3599\u20133726","journal-title":"Eur Heart J"},{"key":"5246_CR24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.122.062159","volume":"147","author":"F Leyva","year":"2023","unstructured":"Leyva\u00a0F, Israel\u00a0CW, Singh\u00a0J (2023) Declining risk of sudden cardiac death in heart failure: fact or myth? Circulation 147:759\u2013767","journal-title":"Circulation"},{"key":"5246_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0140-6736(23)00875-9","volume":"402","author":"E Marijon","year":"2023","unstructured":"Marijon\u00a0E, Narayanan\u00a0K, Smith\u00a0K et\u00a0al (2023) The Lancet Commission to reduce the global burden of sudden cardiac death: a\u00a0call for multidisciplinary action. Lancet 402:883\u2013936","journal-title":"Lancet"},{"key":"5246_CR26","doi-asserted-by":"crossref","unstructured":"Tfelt-Hansen J, Garcia R, Albert C et\u00a0al (2023) Risk stratification of sudden cardiac death: a\u00a0review. Europace 25:","DOI":"10.1093\/europace\/euad203"},{"key":"5246_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa0909545","volume":"363","author":"GH Bardy","year":"2010","unstructured":"Bardy\u00a0GH, Smith\u00a0WM, Hood\u00a0MA et\u00a0al (2010) An entirely subcutaneous implantable cardioverter-defibrillator. N\u00a0Engl J Med 363:36\u201344","journal-title":"N Engl J Med"},{"key":"5246_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/jce.15511","volume":"33","author":"AE Thompson","year":"2022","unstructured":"Thompson\u00a0AE, Atwater\u00a0B, Boersma\u00a0L et\u00a0al (2022) The development of the extravascular defibrillator with substernal lead placement: a\u00a0new frontier for device-based treatment of sudden cardiac arrest. J\u00a0Cardiovasc Electrophysiol 33:1085\u20131095","journal-title":"J Cardiovasc Electrophysiol"},{"key":"5246_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijcard.2020.08.089","volume":"323","author":"J Kuschyk","year":"2021","unstructured":"Kuschyk\u00a0J, Muller-Leisse\u00a0J, Duncker\u00a0D et\u00a0al (2021) Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies. Int J Cardiol 323:100\u2013105","journal-title":"Int J Cardiol"},{"key":"5246_CR30","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.7326\/M22-1566","volume":"175","author":"JS Healey","year":"2022","unstructured":"Healey\u00a0JS, Krahn\u00a0AD, Bashir\u00a0J et\u00a0al (2022) Perioperative safety and early patient and device outcomes among subcutaneous versus transvenous Implantable cardioverter defibrillator Implantations : a\u00a0randomized, multicenter trial. Ann Intern Med 175:1658\u20131665","journal-title":"Ann Intern Med"},{"key":"5246_CR31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJMoa1915932","volume":"383","author":"RE Knops","year":"2020","unstructured":"Knops\u00a0RE, Olde Nordkamp\u00a0LRA, Delnoy\u00a0PHM et\u00a0al (2020) Subcutaneous or transvenous defibrillator therapy. N\u00a0Engl J Med 383:526\u2013536","journal-title":"N Engl J Med"},{"key":"5246_CR32","unstructured":"Knops RE, Pepplinkhuizen S, Delnoy P et\u00a0al (2022) Device-related complications in the subcutaneous and transvenous ICD: a\u00a0secondary analysis of the PRAETORIAN trial. Eur Heart\u00a0J"},{"key":"5246_CR33","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/eurheartj\/ehab921","volume":"43","author":"PD Lambiase","year":"2022","unstructured":"Lambiase\u00a0PD, Theuns\u00a0DA, Murgatroyd\u00a0F et\u00a0al (2022) Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study. Eur Heart\u00a0J 43:2037\u20132050","journal-title":"Eur Heart J"},{"key":"5246_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jacc.2023.05.034","volume":"82","author":"MR Gold","year":"2023","unstructured":"Gold\u00a0MR, El-Chami\u00a0MF, Burke\u00a0MC et\u00a0al (2023) Postapproval study of a\u00a0subcutaneous Implantable cardioverter-defibrillator system. J\u00a0Am Coll Cardiol 82:383\u2013397","journal-title":"J Am Coll Cardiol"},{"key":"5246_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","volume":"143","author":"MR Gold","year":"2021","unstructured":"Gold\u00a0MR, Lambiase\u00a0PD, El-Chami\u00a0MF et\u00a0al (2021) Primary results from the understanding outcomes with the S\u2011ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial. Circulation 143:7\u201317","journal-title":"Circulation"},{"key":"5246_CR36","doi-asserted-by":"crossref","unstructured":"Knops RE, El-Chami MF, Marquie C et\u00a0al (2024) The predictive value of the PRAETORIAN score for defibrillation test success in subcutaneous ICD patients: a\u00a0sub-analysis of the PRAETORIAN-DFT trial. Heart Rhythm","DOI":"10.1016\/j.hrthm.2024.02.005"},{"key":"5246_CR37","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.hroo.2023.05.004","volume":"4","author":"MS Lloyd","year":"2023","unstructured":"Lloyd\u00a0MS, Brisben\u00a0AJ, Reddy\u00a0VY et\u00a0al (2023) Design and rationale of the MODULAR ATP global clinical trial: A\u00a0novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm O2 4:448\u2013456","journal-title":"Heart Rhythm O2"},{"key":"5246_CR38","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","volume":"35","author":"RE Kirkfeldt","year":"2014","unstructured":"Kirkfeldt\u00a0RE, Johansen\u00a0JB, Nohr\u00a0EA et\u00a0al (2014) Complications after cardiac implantable electronic device implantations: an analysis of a\u00a0complete, nationwide cohort in Denmark. Eur Heart\u00a0J 35:1186\u20131194","journal-title":"Eur Heart J"},{"key":"5246_CR39","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1056\/NEJMoa1507192","volume":"373","author":"VY Reddy","year":"2015","unstructured":"Reddy\u00a0VY, Exner\u00a0DV, Cantillon\u00a0DJ et\u00a0al (2015) Percutaneous implantation of an entirely Intracardiac leadless pacemaker. N\u00a0Engl J Med 373:1125\u20131135","journal-title":"N Engl J Med"},{"key":"5246_CR40","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1056\/NEJMoa2300080","volume":"388","author":"RE Knops","year":"2023","unstructured":"Knops\u00a0RE, Reddy\u00a0VY, Ip\u00a0JE et\u00a0al (2023) A dual-chamber leadless pacemaker. N\u00a0Engl J Med 388:2360\u20132370","journal-title":"N Engl J Med"},{"key":"5246_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.hrthm.2023.09.017","volume":"21","author":"GH Crossley","year":"2024","unstructured":"Crossley\u00a0GH, Longacre\u00a0C, Higuera\u00a0L et\u00a0al (2024) Outcomes of patients implanted with an atrioventricular synchronous leadless ventricular pacemaker in the Medicare population. Heart Rhythm 21:66\u201373","journal-title":"Heart Rhythm"},{"key":"5246_CR42","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/jce.15863","volume":"34","author":"GH Crossley","year":"2023","unstructured":"Crossley\u00a0GH, Piccini\u00a0JP, Longacre\u00a0C et\u00a0al (2023) Leadless versus transvenous single-chamber ventricular pacemakers: 3\u00a0year follow-up of the Micra CED study. J\u00a0Cardiovasc Electrophysiol 34:1015\u20131023","journal-title":"J Cardiovasc Electrophysiol"},{"key":"5246_CR43","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/europace\/euac066","volume":"24","author":"LV Boersma","year":"2022","unstructured":"Boersma\u00a0LV, El-Chami\u00a0M, Steinwender\u00a0C et\u00a0al (2022) Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a\u00a0position paper by EHRA\/HRS\/LAHRS\/APHRS. Europace 24:1691\u20131708","journal-title":"Europace"},{"key":"5246_CR44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/europace\/euz246","volume":"22","author":"C Blomstrom-Lundqvist","year":"2020","unstructured":"Blomstrom-Lundqvist\u00a0C, Traykov\u00a0V, Erba\u00a0PA et\u00a0al (2020) European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace 22:515\u2013549","journal-title":"Europace"},{"key":"5246_CR45","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.hrthm.2011.04.014","volume":"8","author":"RE Kirkfeldt","year":"2011","unstructured":"Kirkfeldt\u00a0RE, Johansen\u00a0JB, Nohr\u00a0EA et\u00a0al (2011) Risk factors for lead complications in cardiac pacing: a\u00a0population-based cohort study of 28,860 Danish patients. Heart Rhythm 8:1622\u20131628","journal-title":"Heart Rhythm"},{"key":"5246_CR46","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/j.jacc.2018.09.068","volume":"72","author":"AD Krahn","year":"2018","unstructured":"Krahn\u00a0AD, Longtin\u00a0Y, Philippon\u00a0F et\u00a0al (2018) Prevention of arrhythmia device infection trial: the PADIT trial. J\u00a0Am Coll Cardiol 72:3098\u20133109","journal-title":"J Am Coll Cardiol"},{"key":"5246_CR47","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","volume":"368","author":"DH Birnie","year":"2013","unstructured":"Birnie\u00a0DH, Healey\u00a0JS, Wells\u00a0GA et\u00a0al (2013) Pacemaker or defibrillator surgery without interruption of anticoagulation. N\u00a0Engl J Med 368:2084\u20132093","journal-title":"N Engl J Med"},{"key":"5246_CR48","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","volume":"39","author":"DH Birnie","year":"2018","unstructured":"Birnie\u00a0DH, Healey\u00a0JS, Wells\u00a0GA et\u00a0al (2018) Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). Eur Heart\u00a0J 39:3973\u20133979","journal-title":"Eur Heart J"},{"key":"5246_CR49","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1161\/CIR.0000000000001187","volume":"149","author":"LM Baddour","year":"2024","unstructured":"Baddour\u00a0LM, Esquer Garrigos\u00a0Z, Sohail\u00a0RM et\u00a0al (2024) Update on cardiovascular Implantable electronic device infections and their prevention, diagnosis, and management: a\u00a0scientific statement from the American heart association: endorsed by the international society for cardiovascular infectious diseases. Circulation 149:e201\u2013e216","journal-title":"Circulation"},{"key":"5246_CR50","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMoa1901111","volume":"380","author":"KG Tarakji","year":"2019","unstructured":"Tarakji\u00a0KG, Mittal\u00a0S, Kennergren\u00a0C et\u00a0al (2019) Antibacterial envelope to prevent cardiac implantable device infection. N\u00a0Engl J Med 380:1895\u20131905","journal-title":"N Engl J Med"},{"key":"5246_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jacep.2021.08.009","volume":"8","author":"KG Tarakji","year":"2022","unstructured":"Tarakji\u00a0KG, Krahn\u00a0AD, Poole\u00a0JE et\u00a0al (2022) Risk factors for CIED infection after secondary procedures: insights from the WRAP-IT trial. JACC Clin Electrophysiol 8:101\u2013111","journal-title":"JACC Clin Electrophysiol"},{"key":"5246_CR52","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/europace\/euaa367","volume":"23","author":"H Burri","year":"2021","unstructured":"Burri\u00a0H, Starck\u00a0C, Auricchio\u00a0A et\u00a0al (2021) EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the heart rhythm society (HRS), the asia pacific heart rhythm society (APHRS), and the Latin-American heart rhythm society (LAHRS). Europace 23:983\u20131008","journal-title":"Europace"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-024-05246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-024-05246-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-024-05246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T15:02:05Z","timestamp":1716994925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-024-05246-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,6]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["5246"],"URL":"https:\/\/doi.org\/10.1007\/s00059-024-05246-1","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,6]]},"assertion":[{"value":"19 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>J.\u00a0Kuschyk<\/b> weist auf folgende Interessenkonflikte hin: Beratert\u00e4tigkeit bei Impulse Dynamics und Boston Scientific. <b>K.\u00a0Sattler, F.\u00a0Fastenrath, B.\u00a0Rudic<\/b> und <b>I.\u00a0Akin<\/b> geben an, dass kein Interessenkonflikt besteht.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}